 
                                  Vallabh Janardhan: Strokes Affecting Younger Patients
Vallabh Janardhan, Co-Founder and CMO at Insera Therapeutics, Inc., posted on LinkedIn:
”Blood clots causing strokes can strike anyone – at any age, any time. Awareness truly saves lives.
Here’s a prior NBC5 News story featuring my interview on how younger people – especially women – can also be at risk.
Watch here NBC5: Strokes Affecting Younger Patients
During and after childbirth, dehydration and natural changes in clotting may lead to Cerebral Venous Sinus Thrombosis – a blockage-type stroke caused by blood clots in the brain’s veins.
Certain genetic factors, such as a prothrombin gene mutation, can further raise risk – especially in women who smoke and use birth control pills.
Behind every breakthrough device or treatment is one critical truth: recognizing blood clots and the early signs and symptoms saves lives.
Know the signs and symptoms of a stroke – BE FAST:
Balance | Eyes | Face | Arms | Speech | Time to call 911
Every second counts. Every person counts.”
Stay informed with Hemostasis Today.
- 
                    Oct 31, 2025, 14:17When Stories Save Lives: Reza Shojaei Shares Blood and Plasma Pulse Newest Issue
- 
                    Oct 31, 2025, 13:34Charlotte Pilling Invites You to ''Women in Hematology'' US Focus Meeting
- 
                    Oct 30, 2025, 12:12Laura Ceci Galanos Reflects on WSC 2025
- 
                    Oct 30, 2025, 07:56Vallabh Janardhan: Strokes Affecting Younger Patients
- 
                    Oct 30, 2025, 07:55“Marrow Asleep or Awake?”: William Aird Simplifies Anemia Diagnosis
- 
                    Oct 31, 2025, 13:47Bethany Brown and Colleagues Present Recommendations on DEHP Alternatives
- 
                    Oct 30, 2025, 07:52Haemophilia B - An illustrative review of current challenges and opportunities
- 
                    Oct 30, 2025, 05:14Umberto Pensato on Reperfusion Outcomes in Stroke
- 
                    Oct 29, 2025, 07:39Pablo Corral: Pushing the Limits of LDLc: Emerging Paradigms in CV Risk Reduction
- 
                    Oct 29, 2025, 07:38Thijs van Haaps and Team Show That Andexanet Alfa May Go Beyond Apixaban and Rivaroxaban
- 
                    Oct 29, 2025, 07:31The Use of Artificial Intelligence to Improve Detection of Acute Incidental Pulmonary Emboli - JTH
- 
                    Oct 29, 2025, 07:05Shrinidhi Nathany: AI in Diagnostic Medicine
- 
                    Oct 28, 2025, 07:02Aya Berman: AI Model for Predicting Bacteremia
- 
                    Oct 28, 2025, 06:55The New Era of Genomics, AI and Cell Therapy in Hematology and Infectious Diseases
- 
                    Oct 28, 2025, 06:49Lukas Gaats: Researchers Are Building Reproductive Organoids
- 
                    Oct 31, 2025, 14:41Emilya Huseynova Reflects on AABB 2025
- 
                    Oct 31, 2025, 14:33Cihan Ay Delivers Seminar at McMaster University on Thrombosis Research
- 
                    Oct 31, 2025, 14:25Thomas Reiser Steps Down as ISTH Executive Director After 14+ Years of Leadership
- 
                    Oct 31, 2025, 14:02Murray Adams Reflects on His Week Attending Blood 2025
- 
                    Oct 31, 2025, 13:10Angelique Balguid: World Stroke Day is More Than a Moment — It’s a Movement
